Variables | Observation | HR | 95%CI | p value of Q | I2 (%) | Tau2 | Q-statistic | P value of estimate |
---|---|---|---|---|---|---|---|---|
Functional status | Â | |||||||
 Working (ref) | 4 | 1 |  |  |  |  |  |  |
 Ambulatory | 1.46 | [0.84, 2.51] | p = 0.001 | 78.8 | 0.29 | 18.83 | p = 0.18 | |
 Bedridden | 2.01 | [1.21, 3.35] | p = 0.137 | 42.7% | 0.13 | 6.98 | p = 0.007 | |
Anemia status | Â | |||||||
 Not anemic (ref) | 8 | 1 |  |  |  |  |  | p < 0.001 |
 Anemic | 2.30 | [1.75, 3.02] | p = 0.179 | 31.2 | 0.05 | 10.17 | ||
WHO clinical staging | Â | |||||||
 Stage I/II (ref) | 10 | 1 |  |  |  |  |  | p < 0.001 |
 Stage III/IV | 2.26 | [1.70, 3.02] | p = 0.048 | 47.2 | 0.09 | 17.05 | ||
Cotrimoxazole preventive therapy | Â | |||||||
 Yes(ref) | 5 | 1 |  |  |  |  |  | p = 0.007 |
 No | 2.16 | [1.23, 3.72] | p = 0.062 | 55.3 | 0.20 | 8.95 | ||
Isoniazid preventing therapy | Â | |||||||
 Yes (ref) | 7 | 1 |  |  |  |  |  | p = 0.001 |
 No | 3.67 | [1.73, 7.76] | p < 0.001 | 79.1 | 0.74 | 28.7 | ||
CD4 cell count | Â | |||||||
 Greater than 200 | 6 | 1 |  |  |  |  |  | p = 0.002 |
 Less than or equal to 200 | 2.12 | [1.31, 3.43] | p < 0.001 | 90.8 | 0.32 | 54.38 | ||
Previous history of tuberculosis | Â | |||||||
 No | 3 | 1 |  |  |  |  |  |  |
 Yes | 1.49 | [0.77, 2.89] | p = 0.004 | 73.5 | 0.39 | 15.11 | p = 0.24 | |
Gender | Â | |||||||
 Female | 5 | 1 |  |  |  |  |  |  |
 Male | 1.37 | [1.16, 1.63] | p = 0.588 | 0 | 0 | 2.82 | p < 0.001 | |
Family size | ||||||||
 Less than five |  | 1 |  |  |  |  |  |  |
 Five or more | 3 | 1.18 | [0.89, 1.56] | p = 0.29 | 19.0 | 0.01 | 2.47 | p = 0.26 |